Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Rapid Dose Therapeutics Corp.

Market Cap 20.28M 14.45M 12.47M 11.46M 10.79M 1.36B 20.45M 136M 52.9M 669M 54.25M 53.09M 2.32B P/E 2024
-4.27x
P/E 2025 -3.92x
Enterprise Value 22.87M 16.3M 14.06M 12.93M 12.17M 1.54B 23.06M 153M 59.65M 755M 61.18M 59.87M 2.61B EV / Sales 2024
22.5x
EV / Sales 2025 11.8x
Free-Float
84.78%
Yield 2024 *
-
Yield 2025 -
1 day-80.00%
1 week-80.00%
Current month-82.63%
1 month-83.01%
3 months-81.14%
6 months-87.66%
Current year-85.33%
1 week 0.01
Extreme 0.0132
0.07
1 month 0.01
Extreme 0.0132
0.08
Current year 0.01
Extreme 0.0132
0.12
1 year 0.01
Extreme 0.006
0.15
3 years 0
Extreme 0.0021
0.39
5 years 0
Extreme 0.0004
1.11
10 years 0
Extreme 0
1.11
Manager TitleAgeSince
Chief Executive Officer - 2017-05-02
Director of Finance/CFO - 2020-02-27
Corporate Officer/Principal - 2019-12-05
Director TitleAgeSince
Chairman - -
Director/Board Member - 2024-08-05
Director/Board Member - 2020-08-12
Change 5-day change 1-year change 3-year change Capi.($)
-80.00%-80.00% - - 8.29M
-0.11%+0.32%+7.24%-51.76% 120M
-4.39%-3.19%+73.82%+23.19% 87.59M
+4.91%-1.16%-17.47%-70.58% 86.33M
Average -19.82%-1.37%+21.20%-33.05% 97.94M
Weighted average by Cap. -2.02%-1.15%+19.83%-34.95%

Financials

2024 2025
Net sales 1.02M 727K 628K 577K 543K 68.65M 1.03M 6.84M 2.66M 33.69M 2.73M 2.67M 117M 2.09M 1.49M 1.28M 1.18M 1.11M 140M 2.1M 13.97M 5.44M 68.85M 5.58M 5.46M 238M
Net income -4.31M -3.07M -2.65M -2.43M -2.29M -290M -4.34M -28.86M -11.23M -142M -11.52M -11.28M -492M -5.4M -3.85M -3.32M -3.06M -2.88M -364M -5.45M -36.21M -14.1M -178M -14.46M -14.15M -617M
Net Debt 2.29M 1.63M 1.41M 1.3M 1.22M 154M 2.31M 15.36M 5.98M 75.7M 6.13M 6M 262M 2.59M 1.85M 1.59M 1.46M 1.38M 174M 2.61M 17.35M 6.75M 85.48M 6.93M 6.78M 296M
Logo Rapid Dose Therapeutics Corp.
Rapid Dose Therapeutics Corp. is a Canadian biotechnology company. It provides disruptive drug delivery technologies designed to improve patient outcomes. Its flagship product, QuickStrip, is a thin, orally dissolvable film that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals, and vaccines, that are delivered quickly into the bloodstream, resulting in rapid onset of the active ingredient. It has one operating segment comprising production, distribution, research, and the provision of technical services for the delivery of oral thin film strips containing active ingredients. It offers over-the-counter and pharmaceutical drug delivery solutions. Its QuickStrip Energy delivers energizing caffeine. Its QuickStrip B12 delivers vitamin B12 to the system, assisting with metabolism and physical energy. Its QuickStrip Sleep delivers melatonin to the system, inducing natural and healthy sleep. QuickStrip Lidocaine is its dental product.
Employees
-
Date Price Change Volume
26-06-17 0.0132 $ -80.00% 3,896
26-06-12 0.0660 $ +1.38% 1,000
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!